BDB563898

CD8A Rat anti-Mouse, Brilliant Violet 421, Clone: 53-6.7, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB563898-Each-of-1 In Stock ₹ 25,276.00

BDB563898 - Each of 1

₹ 25,276.00

In Stock

Quantity

1

Base Price: ₹ 25,276.00

GST (18%): ₹ 4,549.68

Total Price: ₹ 29,825.68

Antigen

CD8a

Classification

Monoclonal

Concentration

0.2mg/mL

Description

Cd8a; CD8 alpha chain; Ly-2; Lyt2; Lyt-2; Ly-35; Ly-B

Host Species

Rat

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Mouse

Isotype

IgG2a κ

Applications

Flow Cytometry

Clone

53-6.7

Conjugate

Brilliant Violet 421

Formulation

Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

Immunogen

Mouse thymus / spleen Cells

Quantity

50 μg

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Related Products

Img

BD Biosciences

BDB563068

--

Img

BD Biosciences

BDB563234

--

Img

BD Biosciences

BDB563152

--

Img

BD Biosciences

BDB563332

--

Img

BD Biosciences

BDB561966

--

Img

BD Biosciences

BDB563194

--

Img

BD Biosciences

BDB563890

--

Img

BD Biosciences

BDB563008

--

Description

  • The 53-6.7 antibody monoclonal antibody specifically binds to the 38 kDa α and 34 kDa α chains of the CD8 differentiation antigen (Ly-2 or Lyt-2) of all mouse strains tested
  • The CD8 α and α chains (CD8a) form heterodimers with the CD8 β chain (CD8b, Ly-3, or Lyt-3) on the surface of most thymocytes
  • A subpopulation of mature T lymphocytes (i.e., MHC class I-restricted T cells, including most T suppressor/cytotoxic cells) expresses almost exclusively the CD8 αβ heterodimer (the α α chains arise from alternatively spliced messengers of a single CD8a gene
  • The longer α form associates with p56 [lck] via a CXCP motif in its cytoplasmic domain, which it shares with CD4, but not with CD8b
  • The truncated α chain is unable to associate with p56 [lck], and it may function to attenuate the CD8-mediated costimulatory signal during intrathymic T-cell maturation
  • In vivo and in vitro treatment with 53-6.7 mAb has reportedly been effective at depleting CD8+ peripheral T lymphocytes
  • The 53-6.7 antibody has also been reported to cross-reaact with CD8 α - and α -like polypeptides on subsets of thymic and peripheral lymphocytes in the Egyptian toad, Bufo regularis
  • The antibody was conjugated to BD Horizon™ BV421 which is part of the BD Horizon™ Brilliant Violet™ family of dyes
  • With an Ex Max of 407-nm and Em Max at 421-nm, BD Horizon™ BV421 can be excited by the violet laser and detected in the standard Pacific Blue™ filter set (eg, 450/50-nm filter)
  • BD Horizon™ BV421 conjugates are very bright, often exhibiting a 10 fold improvement in brightness compared to Pacific Blue™ conjugates.